Analog Devices Inc. Chair and CEO Vincent Roche filed a Form 4 on November 3, 2026, disclosing transactions in Analog Devices common stock dated November 2, 2026, including the exercise of a stock option and a sale of 10,000 shares under a pre-established 10b5-1 plan.

Key Highlights

  • Option exercised: Roche exercised a fully vested Non-Qualified Stock Option for 10,000 shares at an exercise price of $108.08 per share on November 2, 2026.
  • Shares sold: 10,000 shares of common stock were sold at $425.46 per share on November 2, 2026, pursuant to a 10b5-1 plan adopted December 3, 2025.
  • Direct holdings after transactions: Roche directly owned 125,670.083 shares following the reported transactions.
  • Indirect holdings: 50,000 shares are held indirectly through the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026.
  • Remaining options: 40,803 Non-Qualified Stock Options remain beneficially owned following the reported exercise, with an expiration date of March 13, 2029.

Roche's November 2026 Option Exercise and Planned Share Sale at Analog Devices

According to the filing, Vincent Roche, Chair and Chief Executive Officer of Analog Devices Inc. (NASDAQ:ADI), reported two transactions in Analog Devices common stock (par value $.16-2/3) on November 2, 2026. First, Roche exercised a Non-Qualified Stock Option covering 10,000 shares at a conversion price of $108.08 per share, acquiring those shares directly. The filing notes the option was fully vested at the time of exercise and carries an expiration date of March 13, 2029.

Immediately following the option exercise, the filing discloses that Roche disposed of 10,000 shares at $425.46 per share. The filing states these shares "were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 3, 2025," indicating the sale was made under a pre-arranged trading instruction. Following both transactions, Roche's direct beneficial ownership stood at 125,670.083 shares, according to the filing.

The filing also reports 50,000 shares held indirectly through the Vincent Roche 2026 Grantor Retained Annuity Trust dated January 11, 2026. After the option exercise, 40,803 Non-Qualified Stock Options remain in Roche's direct beneficial ownership. The Form 4 was signed by Shelly Shaw, General Counsel, by power of attorney, and was filed on November 3, 2026. The filing also indicates, via a checked box, that the sale transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

What Was Disclosed

Analog Devices Chair and CEO Vincent Roche disclosed a November 2, 2026 option exercise of 10,000 shares at $108.08 and a same-day sale of 10,000 shares at $425.46, with the sale made under a 10b5-1 plan established December 3, 2025. Direct ownership following the transactions was 125,670.083 shares.